We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Siemens and LabCorp Enter Agreement to Co-Develop Clinical Diagnostic Tests
News

Siemens and LabCorp Enter Agreement to Co-Develop Clinical Diagnostic Tests

Siemens and LabCorp Enter Agreement to Co-Develop Clinical Diagnostic Tests
News

Siemens and LabCorp Enter Agreement to Co-Develop Clinical Diagnostic Tests

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Siemens and LabCorp Enter Agreement to Co-Develop Clinical Diagnostic Tests"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Siemens Healthcare and Laboratory Corporation of America® Holdings (LabCorp®) have entered a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes. Under the agreement, initial discussions will focus on developing new tests that could make the biggest impact to patient care.

Companion diagnostics are tests designed to identify the suitability between patients and a particular drug therapy. The tests can be used in personalized medicine to improve safety and efficacy of therapeutic drugs and in some cases, may help determine optimal dosing for individual patients.

"This agreement establishes a framework that gives both companies the opportunity to offer new diagnostic tests to laboratories, physicians and their patients more quickly and effectively than either could do alone," said Dave Hickey, senior vice president strategic planning and business development, Siemens Healthcare Diagnostics.

"Advancing health care for patients is an important commitment that we can reach through strategic relationships such as this."

Advertisement